EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nano‐Therapeutics for In Vivo Immune Cell Engineering

Yuanyuan Geng, Ziqi Wang, Xiaoyun Liu, Haochen Yao, Jiali Sun, Yeh-Hsing Lao, Shixian Lv, Xi Xie, Yu Tao, Mingqiang Li iD

Small Methods · 2026

DOI: 10.1002/smtd.202501973 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small Methods, 2026. Verfasst von Yuanyuan Geng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Chi…. Hauptthemen laut MEDLINE: Cell Engineering, Nanomedicine, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province for Distinguished Young Scholar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune cell engineering, exemplified by chimeric antigen receptor T (CAR‐T) cell therapy, has revolutionized the treatment of various diseases, particularly cancers. While significant advancements have been made in ex vivo immune cell editing, progress in in vivo engineering has been comparatively slower despite its substantial potential advantages, such as reduced manufacturing complexity and cost. However, in vivo approaches face critical challenges, including insufficient targeting specificity, limited editing efficiency, and uncertain long‐term safety profiles. These limitations necessitate the exploration of nano‐strategies to overcome biological barriers. This review summarizes the advantages of in vivo over ex vivo immune cell engineering, discusses the latest research progress in nano‐therapeutics for in vivo immune cell engineering, and highlights applications across diverse diseases. Finally, we examine critical barriers hindering clinical translation and offer perspectives on future developments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell EngineeringNanomedicineNanoparticlesHumansAnimalsImmunotherapyReceptors, Chimeric AntigenNeoplasmsImmunotherapy, Adoptive

Stichwörter der Autor:innen

biomaterialdrug deliveryimmune cell engineeringimmunotherapynanomedicine

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Key Laboratory and Engineering Laboratory of Lymphatic Surgery of Jilin Province, China-Japan Union Hospital, Jilin University, Changchun, China.
  • Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, College of Basic Medicine, Jilin University, Changchun, China.
  • Department of Pharmaceutical Sciences, University At Buffalo, The State University of New York, Buffalo, New York, USA.
  • School of Materials Science and Engineering, Peking University, Beijing, China.
  • State Key Laboratory of Optoelectronic Materials and Technologies, Guangdong Province Key Laboratory of Display Material and Technology, School of Electronics and Information Technology, Sun Yat-sen University, Guangzho…

ORCID-Profile: Mingqiang Li

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province for Distinguished Young Scholar
  • Science and Technology Program of Guangzhou
  • China Primary Health Care Foundation

Zitieren

APA

Geng, Y., Wang, Z., Liu, X., Yao, H., Sun, J., Lao, Y. H., Lv, S., Xie, X., Tao, Y., & Li, M. (2026). Nano‐Therapeutics for In Vivo Immune Cell Engineering. Small Methods. https://doi.org/10.1002/smtd.202501973

Vancouver

Geng Y, Wang Z, Liu X, Yao H, Sun J, Lao YH, et al. Nano‐Therapeutics for In Vivo Immune Cell Engineering. Small Methods. 2026. doi:10.1002/smtd.202501973

BibTeX
@article{Geng2026,
  author = {Geng, Yuanyuan and Wang, Ziqi and Liu, Xiaoyun and Yao, Haochen and Sun, Jiali and Lao, Yeh-Hsing and Lv, Shixian and Xie, Xi and Tao, Yu and Li, Mingqiang},
  title = {Nano‐Therapeutics for In Vivo Immune Cell Engineering},
  journal = {Small Methods},
  year = {2026},
  doi = {10.1002/smtd.202501973}
}
Kostenlos starten →